1. Home
  2. GRFS vs G Comparison

GRFS vs G Comparison

Compare GRFS & G Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$8.48

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Logo Genpact Limited

G

Genpact Limited

HOLD

Current Price

$36.54

Market Cap

5.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRFS
G
Founded
1940
1997
Country
Spain
Bermuda
Employees
25247
140000
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
5.8B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
GRFS
G
Price
$8.48
$36.54
Analyst Decision
Hold
Buy
Analyst Count
2
6
Target Price
$10.15
$49.50
AVG Volume (30 Days)
649.3K
2.2M
Earning Date
07-28-2022
05-07-2026
Dividend Yield
1.63%
2.03%
EPS Growth
N/A
9.82
EPS
N/A
3.13
Revenue
N/A
$2,279,438,000.00
Revenue This Year
$4.69
$9.20
Revenue Next Year
$6.49
$7.27
P/E Ratio
$18.67
$11.80
Revenue Growth
N/A
N/A
52 Week Low
$6.90
$33.92
52 Week High
$11.14
$50.24

Technical Indicators

Market Signals
Indicator
GRFS
G
Relative Strength Index (RSI) 53.66 45.30
Support Level $8.27 $34.36
Resistance Level $9.08 $38.42
Average True Range (ATR) 0.21 1.08
MACD 0.09 0.12
Stochastic Oscillator 67.73 58.78

Price Performance

Historical Comparison
GRFS
G

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About G Genpact Limited

Genpact Ltd is an agentic, technology-solutions company offering digital transformation, data-driven operations, and technology-enabled services across multiple industries. Its core business services include decision support services; technology services like application lifecycle management, platform customization, and support, etc; and digital operations optimizing business processes. Genpact also offers data engineering, data management, and domain-based AI and generative AI solutions; develops new technology solutions for clients; and offers agentic solutions and technology consulting services. Its reportable segments are: High Tech and Manufacturing, which generate maximum revenue, Financial Services, and Consumer and Healthcare. Geographically, it derives maximum revenue from India.

Share on Social Networks: